Brachman PS, Gold H, Plotkin S, Fekety FR, Werrin M, Ingraham NR. 1962. Field evaluation of a human anthrax vaccine. Am J Public Health 52:632–645.
Brown MA, Brix KA. 1998. Review of health consequences from high-, intermediate-and low-level exposure to organophosphorous nerve agents. J Appl Toxicol 18(6): 393–408.
Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM Jr. 1997. Biological warfare. A historical perspective. JAMA 278(5):412–417.
CIA–DoD (Central Intelligence Agency and Department of Defense). 1997. Modeling the Chemical Warfare Agent Release at the Khamisiyah Pit. Washington, DC: CIA– DoD.
Coiro V, Volpi R, Marchesi C, DeFerri A, Capretti L, Caffarri G, Colla R, Chiodera P. 1998. Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis. Metabolism 47(1):50–53.
Committee on Veterans’ Affairs, U.S. Senate. 1998. Report of the Special Investigation Unit on Gulf War Illnesses. 105th Congress, 2nd session. S.PRT 105-39. Washington, DC: U.S. Government Printing Office.
Cordido F, Penalva A, Peino R, Casanueva FF, Dieguez C. 1995. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects. Metabolism 44(6):745–748.
Dupree EA, Watkins JP, Ingle JN, Wallace PW, West CM, Tankersley WG. 1995. Uranium dust exposure and lung cancer risk in four uranium processing operations. Epidemiology 6(4):370–375.
Ellenberg SS. 1999. Statement at the July 21, 1999, hearing of the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, U.S. House of Representatives. Rockville, MD: Food and Drug Administration.
Evans AS. 1976. Causation and disease: The Henle–Koch postulates revisited. Yale J Biol Med 49(2):175–195.
Fahey D. 2000. Don’t Look, Don’t Find: Gulf War Veterans, the U.S. Government and Depleted Uranium. Lewiston, ME: Military Toxics Project.
Fiock MA, Devine LF, Gearinger NF, Duff JT, Wright GG, Kadull PJ. 1962. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid. J Immunol 88:277–283.
Fiock MA, Cardella MA, Gearinger NF. 1963. Studies on immunity to toxins of Clostridium botulinum. X. Immunologic response of man to purified pentavalent ABCDE botulinum toxoid. J Immunol 90:697–702.
Frome EL, Cragle DL, McLain RW. 1990. Poisson regression analysis of the mortality among a cohort of World War II nuclear industry workers. Radiat Res 123(2):138–152.
GAO (U.S. General Accounting Office). 1999. Medical Readiness: Safety and Efficacy of the Anthrax Vaccine . Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives. GAO/T-NSIAD-99-148. Washington, DC: GAO.
Ghigo E, Arvat E, Mazza E, Mondardini A, Cappa M, Muller EE, Cammani F. 1990a. Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night. Acta Endocrinol (Copenh) 122(1):37–40.